Cargando…
High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice
Although improvements in technology for the isolation of potential therapeutic antibodies have made the process increasingly predictable, the development of biologically active monoclonal antibodies (mAbs) into drugs can often be impeded by developability issues such as poor expression, solubility,...
Autores principales: | Kelly, Ryan L, Sun, Tingwan, Jain, Tushar, Caffry, Isabelle, Yu, Yao, Cao, Yuan, Lynaugh, Heather, Brown, Michael, Vásquez, Maximiliano, Wittrup, K Dane, Xu, Yingda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622737/ https://www.ncbi.nlm.nih.gov/pubmed/26047159 http://dx.doi.org/10.1080/19420862.2015.1043503 |
Ejemplares similares
-
An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies
por: Estep, Patricia, et al.
Publicado: (2015) -
Understanding ForteBio’s Sensors for High-Throughput Kinetic and Epitope Screening for Purified Antibodies and Yeast Culture Supernatant
por: Yu, Yao, et al.
Publicado: (2016) -
Assessing the binding properties of the anti-PD-1 antibody landscape using label-free biosensors
por: Brown, Michael E., et al.
Publicado: (2020) -
Deamidation and isomerization liability analysis of 131 clinical-stage antibodies
por: Lu, Xiaojun, et al.
Publicado: (2018) -
The uniqueness of flow in probing the aggregation behavior of clinically relevant antibodies
por: Willis, Leon F., et al.
Publicado: (2020)